Empyrean Therapeutics, Inc. | Finanzwire

Basculer en Français

8402	Companies
122494	Keywords
60929	Articles
65768	Press releases

Headlines Articles Press releases Empyrean Therapeutics, Inc.

Home
Companies
Empyrean Therapeutics, Inc.

BRIEF

published on 11/25/2024 at 23:25, 1 month 1 day ago

Empyrean Therapeutics Acquires Novel Cancer Treatment Molecule

Cancer Treatment Pharmaceutical Acquisition Empyrean Therapeutics TLR-2 Antagonist R&D Innovation
PRESS RELEASE

published on 11/25/2024 at 23:20, 1 month 1 day ago

Empyrean Therapeutics Acquires TLR-2 Antagonist Molecule From Eos Therapies to Advance and Commercialize Breakthrough Cancer Treatment
Empyrean Therapeutics, Inc. acquires novel cancer drug molecule EMS-312 from Eos Therapies, aiming to expedite development for brain, pancreatic, breast, and hard-to-treat cancers. Strategic move marks milestone. CEOs Kal Fishman and Doug Bonhaus express optimism

Empyrean Therapeutics Novel Cancer Drug EMS-312 Eos Therapies CEO Kal Fishman

Accesswire

Published on 12/26/2024 at 21:20, 8 hours 21 minutes ago

Valsoft Corporation Secures $150M to Further Accelerate Growth in Vertical Market Software Sector
Published on 12/26/2024 at 20:00, 9 hours 41 minutes ago

Breaking Update - BOI Reporting is Back: New Filing Deadline Set for January 13, 2025
Published on 12/26/2024 at 14:30, 15 hours 11 minutes ago

Network-1 Commences Patent Litigation against Citadel Securities and Jump Trading
Published on 12/26/2024 at 13:15, 16 hours 26 minutes ago

SMX Integrates Its Proprietary Coating and Digital Platform Technology for NFC & RFID Chip Markings and Protection
Published on 12/25/2024 at 01:05, 2 days 4 hours ago

Battery X Metals Announces Closing of Non-Brokered Private Placement and Debt Settlement

View all ACCESSWIRE

EQS Group

Published on 12/26/2024 at 15:09, 14 hours 32 minutes ago

Form 8.3 - The Vanguard Group, Inc.: International Paper Company
Published on 12/26/2024 at 15:08, 14 hours 33 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc
Published on 12/26/2024 at 15:06, 14 hours 35 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Aviva plc
Published on 12/26/2024 at 15:05, 14 hours 36 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Smith (DS) plc
Published on 12/25/2024 at 13:43, 1 day 15 hours ago

EQS-Adhoc: Delivery Hero SE: Taiwan Fair Trade Commission (“TFTC”) does not issue approval for the sale of the foodpanda business in Taiwan to Uber Technologies, Inc (“Uber”)

Les Echos

Published on 12/24/2024 at 20:11, 2 days 9 hours ago

Disclosure of trading in own shares between December 16th and December 20th, 2024
Published on 12/24/2024 at 20:06, 2 days 9 hours ago

Disclosure of trading in own shares between December 9th and December 13th, 2024
Published on 12/24/2024 at 08:32, 2 days 21 hours ago

Cie du Bois Sauvage: Buy back of own shares – week from 16/12/2024 to 20/12/2024
Published on 12/24/2024 at 07:00, 2 days 22 hours ago

Biophytis Will Be In San Franscico During The 2025 JP Morgan Healthcare Conference
Published on 12/23/2024 at 17:45, 3 days 11 hours ago

Report of the Extraordinary General Shareholders’ Meeting

View all LES ECHOS COMFI WIRE